Ciprofloxacin Alvogen (Ciprofloxacin Portfarma) Filmuhúðuð tafla 250 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ciprofloxacin alvogen (ciprofloxacin portfarma) filmuhúðuð tafla 250 mg

alvogen ehf. - ciprofloxacinum hýdróklóríð - filmuhúðuð tafla - 250 mg

Ciprofloxacin Navamedic (Ciprofloxacin Villerton) Innrennslislyf, lausn 2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ciprofloxacin navamedic (ciprofloxacin villerton) innrennslislyf, lausn 2 mg/ml

navamedic asa - ciprofloxacinum laktat - innrennslislyf, lausn - 2 mg/ml

Síprox Tafla 250 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

síprox tafla 250 mg

teva b.v.* - ciprofloxacinum hýdróklóríð - tafla - 250 mg

Síprox Tafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

síprox tafla 500 mg

teva b.v.* - ciprofloxacinum hýdróklóríð - tafla - 500 mg

Azithromycin STADA Filmuhúðuð tafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

azithromycin stada filmuhúðuð tafla 500 mg

stada arzneimittel ag - azithromycinum mónóhýdrat - filmuhúðuð tafla - 500 mg

Azithromycin STADA Mixtúruduft, dreifa 40 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

azithromycin stada mixtúruduft, dreifa 40 mg/ml

stada arzneimittel ag - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml

Zitromax Filmuhúðuð tafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zitromax filmuhúðuð tafla 500 mg

pfizer aps - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg

Zitromax Mixtúruduft, dreifa 40 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zitromax mixtúruduft, dreifa 40 mg/ml

pfizer aps - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml

Zitromax Stofn fyrir innrennslisþykkni, lausn 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zitromax stofn fyrir innrennslisþykkni, lausn 500 mg

pfizer aps - azithromycinum díhýdrat - stofn fyrir innrennslisþykkni, lausn - 500 mg

Eucreas Evrópusambandið - íslenska - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, kvarta stutt og long-term - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.